P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA.

Detalles Bibliográficos
Autores principales: R, Chethan, Singh Malik, Prabath, Kumar Sahoo, Ranjit, Pramannik, Raja, Garg, Vikas, Kirar, Sudhir, Bhatia, Kanupriya, Kantak, Anura, Sharma, Atul, Kumar, Lalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428961/
http://dx.doi.org/10.1097/01.HS9.0000969644.37507.cd

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428961/
http://dx.doi.org/10.1097/01.HS9.0000969644.37507.cd

Ejemplares similares